Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

306 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study.
Ebbo M, Grados A, Guedj E, Gobert D, Colavolpe C, Zaidan M, Masseau A, Bernard F, Berthelot JM, Morel N, Lifermann F, Palat S, Haroche J, Mariette X, Godeau B, Bernit E, Costedoat-Chalumeau N, Papo T, Hamidou M, Harlé JR, Schleinitz N. Ebbo M, et al. Among authors: haroche j. Arthritis Care Res (Hoboken). 2014 Jan;66(1):86-96. doi: 10.1002/acr.22058. Arthritis Care Res (Hoboken). 2014. PMID: 23836437 Free article.
18F-fluorodeoxyglucose-positron emission tomography scanning is more useful in followup than in the initial assessment of patients with Erdheim-Chester disease.
Arnaud L, Malek Z, Archambaud F, Kas A, Toledano D, Drier A, Zeitoun D, Cluzel P, Grenier PA, Chiras J, Piette JC, Amoura Z, Haroche J. Arnaud L, et al. Among authors: haroche j. Arthritis Rheum. 2009 Oct;60(10):3128-38. doi: 10.1002/art.24848. Arthritis Rheum. 2009. PMID: 19790052 Free article.
CNS involvement and treatment with interferon-α are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients.
Arnaud L, Hervier B, Néel A, Hamidou MA, Kahn JE, Wechsler B, Pérez-Pastor G, Blomberg B, Fuzibet JG, Dubourguet F, Marinho A, Magnette C, Noel V, Pavic M, Casper J, Beucher AB, Costedoat-Chalumeau N, Aaron L, Salvatierra J, Graux C, Cacoub P, Delcey V, Dechant C, Bindi P, Herbaut C, Graziani G, Amoura Z, Haroche J. Arnaud L, et al. Among authors: haroche j. Blood. 2011 Mar 10;117(10):2778-82. doi: 10.1182/blood-2010-06-294108. Epub 2011 Jan 14. Blood. 2011. PMID: 21239701 Free article.
IgG4-related systemic disease: features and treatment response in a French cohort: results of a multicenter registry.
Ebbo M, Daniel L, Pavic M, Sève P, Hamidou M, Andres E, Burtey S, Chiche L, Serratrice J, Longy-Boursier M, Ruivard M, Haroche J, Godeau B, Beucher AB, Berthelot JM, Papo T, Pennaforte JL, Benyamine A, Jourde N, Landron C, Roblot P, Moranne O, Silvain C, Granel B, Bernard F, Veit V, Mazodier K, Bernit E, Rousset H, Boucraut J, Boffa JJ, Weiller PJ, Kaplanski G, Aucouturier P, Harlé JR, Schleinitz N. Ebbo M, et al. Among authors: haroche j. Medicine (Baltimore). 2012 Jan;91(1):49-56. doi: 10.1097/MD.0b013e3182433d77. Medicine (Baltimore). 2012. PMID: 22198501 Free article.
The Relapsing Polychondritis Disease Activity Index: development of a disease activity score for relapsing polychondritis.
Arnaud L, Devilliers H, Peng SL, Mathian A, Costedoat-Chalumeau N, Buckner J, Dagna L, Michet C, Sharma A, Cervera R, Haroche J, Papo T, D'Cruz D, Arlet P, Zwerina J, Belot A, Suzuki N, Harle JR, Moots R, Jayne D, Hachulla E, Marie I, Tanaka T, Lebovics R, Scott D, Kucharz EJ, Birchall M, Kong KO, Gorochov G, Amoura Z; RPDAI study group. Arnaud L, et al. Among authors: haroche j. Autoimmun Rev. 2012 Dec;12(2):204-9. doi: 10.1016/j.autrev.2012.06.005. Epub 2012 Jul 5. Autoimmun Rev. 2012. PMID: 22771427 Review.
306 results